Visium Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Visium Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-12,100	Closed	-$696K	–	1041
2015 Q2	$696K	Sell	12,100 -11,700	-49%	-$744K	0.01%	577
2015 Q1	$1.51M	Buy	+23,800	New	+$1.61M	0.02%	469
2014 Q2	–	Sell	-50,000	Closed	-$2.16M	–	1155
2014 Q1	$2.16M	Sell	50,000 -786,400	-94%	-$38.1M	0.04%	372
2013 Q4	$33.3M	Buy	836,400 +44,575	+6%	+$1.59M	0.65%	26
2013 Q3	$29.7M	Buy	791,825 +85,021	+12%	+$2.54M	0.67%	29
2013 Q2	$19M	Buy	+706,804	New	+$15M	0.44%	47

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Visium Asset Management's IONS Position: Q3 2015 in Review

Visium Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2015, closing a stake of 12,100 shares — an estimated $696K sold.

Visium Asset Management first reported a position in IONS in Q2 2013 and held it in 6 quarters. The position peaked at $33.3M in Q4 2013. 314 funds tracked by Wall St. Rank hold IONS as of Q3 2015.

Visium Asset Management reported no remaining Ionis Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Visium Asset Management sold 12,100 Ionis Pharmaceuticals shares in Q3 2015, an estimated $696K.
Visium Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 6 quarters.
Visium Asset Management's Ionis Pharmaceuticals position peaked at $33.3M in Q4 2013.
314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2015.

Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.